“Training the next generation of treatment activists in Central America”
Opinion“Only around half of people living with HIV across Central America have access to life-saving treatment. The picture when it...
Read more about “Training the next generation of treatment activists in Central America”
-
OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
News Opinion“In November 2020, Ukraine finally shifted from the overpriced branded version of darunavir (DRV) to the more affordable generic version of...
Read more about OPINION: Breaking a ‘vicious cycle’ of overpaying for HIV drugs in Ukraine
-
HIV activists are essential to the COVID-19 response
News OpinionThe legacy of HIV activism is approaching a 40-year history, one which is inextricably linked with the actions of pharmaceutical...
Read more about HIV activists are essential to the COVID-19 response
-
COVID-19 & TB: Why whether you live or die is a matter of justice, not science
OpinionJohnson & Johnson, a brand built on images of happy gurgling babies and the tagline ‘no more tears’, has the...
Read more about COVID-19 & TB: Why whether you live or die is a matter of justice, not science
-
New money for old drugs: COVID-19 is not a profit-making opportunity
OpinionTo try to limit the catastrophic impact of COVID-19, a huge amount of funding has been invested into scientific development...
Read more about New money for old drugs: COVID-19 is not a profit-making opportunity
-
Indonesia: Community action results in cheaper HIV treatment
News OpinionFirst published by The Jakarta Post. Indonesia has an increasing rate of new HIV infections, with approximately 46,000 people newly...
Read more about Indonesia: Community action results in cheaper HIV treatment
-
We can’t end AIDS without tackling patent abuse
News OpinionDespite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...
Read more about We can’t end AIDS without tackling patent abuse
-
-
-
